BioCentury
ARTICLE | Financial News

NeuroVia raises $14M in series A

July 20, 2017 3:30 PM UTC

Rare disease company NeuroVia Inc. (San Francisco, Calif.) raised $14 million in a series A round led by Novartis Venture Fund (NVF) and Sanofi-Genzyme BioVentures (SGBV). Also participating were BioMed Ventures and Enso Ventures.

Founder and President Giovanni Ferrara told BioCentury that NeuroVia hopes to begin a clinical trial by year end of lead candidate NV1205 to treat X-linked adrenoleukodystrophy (X-ALD). ...